Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of PomDoctor Ltd. securities, alleging fraudulent activities during the Class Period from October 9, 2025, to December 11, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that PomDoctor was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [5]. - It is alleged that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that PomDoctor's public statements omitted critical information regarding false rumors and artificial trading activity [5]. - The lawsuit asserts that the misleading statements made by the defendants about PomDoctor's business and prospects caused investors to suffer damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased PomDoctor securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must be appointed by April 7, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, further establishing the firm's credibility [4].
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit